Pharmaceutical Business review

Kinetic Concepts files suit against Innovative Therapies

The claims in the suit include breach of confidentiality agreements, conversion of Kinetic Concepts (KCI) technology, theft of trade secrets and conspiracy. KCI is seeking damages and injunctive relief in the case.

Catherine Burzik, president and CEO of KCI, said: “This case represents our continued determination to protect and enforce KCI’s rights to our innovative technologies.”